Cite
Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality.
MLA
Zaidel, Ezequiel J., et al. “Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality.” Global Heart, vol. 15, no. 1, Aug. 2020, p. 52. EBSCOhost, https://doi.org/10.5334/gh.608.
APA
Zaidel, E. J., Leng, X., Adeoye, A. M., Hakim, F., Karmacharya, B., Katbeh, A., Neubeck, L., Partridge, S., Perel, P., Huffman, M. D., & Cesare, M. D. (2020). Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality. Global Heart, 15(1), 52. https://doi.org/10.5334/gh.608
Chicago
Zaidel, Ezequiel J, Xinyi Leng, Abiodun Moshood Adeoye, Ferdous Hakim, Biraj Karmacharya, Asim Katbeh, Lis Neubeck, et al. 2020. “Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality.” Global Heart 15 (1): 52. doi:10.5334/gh.608.